Related Experiment Videos
Emerging perspectives on glaucoma: highlights of a roundtable discussion
M D Lee1, F R Fechtner, R G Fiscella
1Department of Ophthalmology, Jules Stein Eye Institute, UCLA School of Medicine, Los Angeles, California, USA. dalee@psu.edu
American Journal of Ophthalmology
|October 12, 2000
Summary
Patient compliance significantly impacts open-angle glaucoma treatment outcomes. Simple interventions, like once-daily medication, can improve adherence and disease management.
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Open-angle glaucoma management requires consistent patient adherence to therapeutic regimens.
- Patient compliance is a critical, often underestimated, factor in achieving successful treatment outcomes.
- Understanding risk factors for noncompliance is essential for effective glaucoma care.
Framework:
- A roundtable discussion format was employed to explore emerging perspectives.
- The discussion focused on patient compliance, current drug therapy, and treatment options in open-angle glaucoma.
Implementation:
- Physician-patient communication and education are key to improving compliance.
- Enhancing the doctor-patient relationship and utilizing compliance aids can bolster adherence.
- Simplifying treatment regimens, including once-daily dosing, is a practical strategy.
Implications:
- Improving patient compliance through simple, cost-effective interventions can enhance open-angle glaucoma treatment.
- Once-daily dosing of first-line therapies presents an optimal approach for maximizing patient adherence.
- Addressing compliance issues proactively can lead to better long-term disease control and patient outcomes.